Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview
- Apoptosis
- Extrinsic and intrinsic apoptosis pathways
- How cancer cells escape apoptosis
- Caspase-independent pathways
- Death by more than thousand cuts
- Introduction to lisosomes and lysosomal cell death
- Lysosomes - forgotten ''suicide bags'' (1)
- The intracellular dynamic trafficking of lysosomes
- Lysosomes - forgotten ''suicide bags'' (2)
- LMP: lysosomal membrane permeabilization
- Signals leading to LMP
- Effect of microtuble destabilizing agents
- Effect of DNA damaging
- Lysosome cell death pathways study problems
- Detection of LMP: lysosomal pH gradient
- Blue light induces rapid lysosomal leakage
- Detection of LMP using green light
- Detection of LMP: immunostaining
- Detection of LMP: enzymatic activity measurement
- Lysosomal changes in cancer
- Transformation of murine embryonic fribroblasts
- Lysosomal Transformation-associated changes
- MEFs sensitivity to cathepsin-dependent cell death
- Transformation and sensitivity to photooxidation
- How cancer cells escape lysosomal cell death?
- Siramesine - a drug that targets lysosomes
- Siramesine - a sigma-2 receptor ligand
- Siramesine induces apoptosis-like cell death
- Transformation sensitizes NIH 3T3 cells to the drug
- Oral administration of siramesine
- Siramrsine does not induce classic apoptosis
- Siramesine disrupts the lysosomal pH gradient
- Involvement of cystein cathepsins
- Siramesine induces cathepsin release in vitro
- Lysosomes as targets for future cancer therapy
- Thanks
- Thanks to the apo-lab-Copenhagen
Topics Covered
- Cell death in cancer
- Introduction to the lysosomes and lysosomal cell death
- Lysosomal changes in cancer
- Siramesine, a drug that targets lysosomes and kills cancer cells in vitro and in vivo
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Jaattela, M. (2007, October 1). Lysosomal cell death pathways: new possibilities for cancer therapy [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/IXST8279.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Marja Jaattela has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.